The IMPACT of triple versus dual single-inhaler therapy on exacerbations of COPD

In the IMPACT trial, triple inhalation therapy resulted in a lower rate of moderate or severe COPD exacerbations compared with either dual therapy with ICS/LABA or LAMA/LABA, but pneumonia rates were increased. http://ow.ly/pYJn30mgpFp

Detalles Bibliográficos
Autor principal: Dobler, Claudia C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2018
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269168/
https://www.ncbi.nlm.nih.gov/pubmed/30519302
http://dx.doi.org/10.1183/20734735.026418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269168/
https://www.ncbi.nlm.nih.gov/pubmed/30519302
http://dx.doi.org/10.1183/20734735.026418

Ejemplares similares